SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-023668
Filing Date
2024-07-29
Accepted
2024-07-29 08:33:56
Documents
17
Period of Report
2024-07-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20240728_8k.htm   iXBRL 8-K 41402
2 EXHIBIT 4.1 ex_704595.htm EX-4.1 204353
3 EXHIBIT 10.1 ex_704596.htm EX-10.1 325085
4 EXHIBIT 10.2 ex_704597.htm EX-10.2 160121
  Complete submission text file 0001437749-24-023668.txt   1026289

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA wint-20240726.xsd EX-101.SCH 3410
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20240726_def.xml EX-101.DEF 11425
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20240726_lab.xml EX-101.LAB 15311
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20240726_pre.xml EX-101.PRE 11585
19 EXTRACTED XBRL INSTANCE DOCUMENT wint20240728_8k_htm.xml XML 2839
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 241149081
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)